[Antilymphocyte immunoglobulin with an associated antibacterial directed effect. II. The use of the preparation in the overall therapy of chronic lympholeukemia].
Use in the composition of complex therapy of patients suffering from chronic lympholeukemia of antilymphocytic immunoglobulin with an associated antibacterial activity aided normalization of the leukocytic differential count and prevented development of inflammatory and septic complications in these patients.
D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy; D000890:Anti-Infective Agents; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007113:Immunity, Innate / Q000187:drug effects; D007945:Leukemia, Lymphoid / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D008297:Male
D000890:Anti-Infective Agents; D000961:Antilymphocyte Serum
Antilimfotsitarnyi immunoglobulin s assotsiirovannoĭ antibakterial'noĭ napravlennost'iu. Soobshchenie II. Primenenie preparata pri kompleksnoĭ terapii bol'nykh khronicheskim limfoleĭkozom.